Table 2.
Performance of the POD for the diagnosis of HCC in training and validation cohort.
| Cohort | AUC (95% CI) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
|---|---|---|---|---|---|
| Training cohort | 0.967 (0.941–0.993) | 91.43 | 96.20 | 95.52 | 92.68 |
| Validation cohort | 0.955 (0.912–0.999) | 90.0 | 82.0 | 69.23 | 95.0 |
POD, probability of disease; AUC, the area under the ROC curve; HCC, hepatocellular carcinoma; PPV, positive predictive value; NPV, negative predictive value.